Literature DB >> 22250844

Editorial: reducing cardiovascular risk: is low-density lipoprotein-cholesterol (LDL-C) lowering enough?

Michael S Kostapanos1, Niki Katsiki, Moses S Elisaf, Dimitri P Mikhailidis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22250844     DOI: 10.2174/157016112799305085

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


× No keyword cloud information.
  5 in total

Review 1.  Benefit-risk assessment of rosuvastatin in the treatment of atherosclerosis and related diseases.

Authors:  Michael S Kostapanos; Christos V Rizos; Moses S Elisaf
Journal:  Drug Saf       Date:  2014-07       Impact factor: 5.606

2.  High density lipoproteins and type 2 diabetes: Emerging concepts in their relationship.

Authors:  Michael S Kostapanos; Moses S Elisaf
Journal:  World J Exp Med       Date:  2014-02-20

3.  Efficacy of statin monotherapy or in combination with coenzyme a capsule in patients with metabolic syndrome and mixed dyslipidemia.

Authors:  Jiangtao Lai; Bifeng Wu; Tianming Xuan; Shudong Xia; Zhong Liu; Junzhu Chen
Journal:  J Clin Med Res       Date:  2015-04-08

4.  Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study.

Authors:  Manfredi Rizzo; Ali A Rizvi; Angelo Maria Patti; Dragana Nikolic; Rosaria Vincenza Giglio; Giuseppa Castellino; Giovanni Li Volti; Massimiliano Caprio; Giuseppe Montalto; Vincenzo Provenzano; Stefano Genovese; Antonio Ceriello
Journal:  Cardiovasc Diabetol       Date:  2016-12-03       Impact factor: 9.951

5.  Liraglutide Reduces Carotid Intima-Media Thickness by Reducing Small Dense Low-Density Lipoproteins in a Real-World Setting of Patients with Type 2 Diabetes: A Novel Anti-Atherogenic Effect.

Authors:  Dragana Nikolic; Rosaria Vincenza Giglio; Ali A Rizvi; Angelo Maria Patti; Giuseppe Montalto; Francesco Maranta; Domenico Cianflone; Anca Pantea Stoian; Manfredi Rizzo
Journal:  Diabetes Ther       Date:  2020-11-18       Impact factor: 2.945

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.